Weed, Inc. (BUDZ): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2018-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$1.31M
Year ended 2025-12-31
-$1.03M
Trailing 12 months to 2026-06-30
$2.09M2010-12-31: $495.9K2011-12-31: $2.09M2017-12-31: -$2.34M2018-12-31: -$28.22M2019-12-31: -$27.26M2020-12-31: -$3.93M2021-12-31: -$2.67M2022-12-31: -$1.39M2023-12-31: -$718.2K2024-12-31: -$507.4K2025-12-31: -$1.31M-$1.31M
2010-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$1.31Mn/m2026-04-08, From 2025-01-01
2024-12-31-$507.4Kn/m2026-04-08, From 2024-01-01
2023-12-31-$718.2Kn/m2025-03-31, From 2023-01-01
2022-12-31-$1.39Mn/m2024-04-01, From 2022-01-01
2021-12-31-$2.67Mn/m2023-03-31, From 2021-01-01
2020-12-31-$3.93Mn/m2022-03-31, From 2020-01-01
2019-12-31-$27.26Mn/m2021-03-31, From 2019-01-01
2018-12-31-$28.22Mn/c2020-03-30, From 2018-01-01
2017-12-31-$2.34Mn/a2019-04-16, From 2017-01-01
No annual figure between 2011-12-31 and 2017-12-31.
2011-12-31$2.09M+321.1%2012-04-16, From 2011-01-01
2010-12-31$495.9Kn/a2012-04-16, From 2010-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Weed, Inc. (BUDZ)2025-12-31-$1.31Mn/m
NRC Health (NRC)2025-12-31$30.21M-26.7%
Incyte Corp (INCY)2025-12-31$1.61B+967.7%
Icon PLC (ICLR)2025-12-31$825.84M-45.7%
Charles River Laboratories International, Inc. (CRL)2025-12-27$428.47M-27.3%
MaxCyte, Inc. (MXCT)2025-12-31-$47.56Mn/m
Iqvia Holdings Inc. (IQV)2025-12-31$3.33B+0.3%
iSpecimen Inc. (ISPC)2025-12-31-$7.25Mn/m
Absci Corp (ABSI)2025-12-31-$108.58Mn/m

Compare BUDZ, NRC, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗